CClinicalTrials.gg
CompletedNCT02725853ENHANCEUpdated Jan 3, 2022

Enhancing Recovery of Arm Movement in Stroke Patients

An interventional study of tDCS and sham tDCS in Stroke, Arm and Paresis, sponsored by McGill University. Completed at 1 site in Canada. Open to participants aged 25 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-01-03.

Sponsored by McGill University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
25 Years to 80 Years
Sex
All
01

Study summary

Many people who have had a stroke have problems recovering the use of their affected arm and these problems may persist for a long time. The investigators' research will test new ways to boost recovery by using non-painful brain stimulation together with training of arm movements using basic science principles. The training program will be done using the latest technology in rehabilitation such as virtual reality and robotics. The investigators will compare three groups of patients who have had a stroke. Each group will receive different combinations of brain stimulation and arm training. Another aspect of this proposal is that the investigators will do the same training programs in three different countries - Canada, Israel and India. In this way, the investigators will combine knowledge and skills to create training programs that can be applied anywhere in the world and that are not necessarily limited to high-income countries. Also, by combining expertise, the investigators will help to build the capacity to do research in India, a middle-income country that has great potential to contribute new knowledge to rehabilitation medicine.

Read the detailed description

Training approaches based on established principles of motor learning and neural plasticity and non-invasive brain stimulation such as repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation (tDCS) show promise in modulating brain activity in order to enhance upper limb (UL) motor recovery. However, the potential for recovery may still not be attained if training programs do not specifically focus on remediating motor impairment as defined by motor control science. This project is driven by a major theory of motor control (Threshold Control Theory) suggesting that rather than directly specifying motor commands to muscles, descending systems regulate spatial thresholds (STs) of reflexes to generate and control voluntary movement within specific areas of joint space. In patients with stroke, ST control is diminished leading to the appearance of muscle spasticity, weakness and abnormal muscle activation patterns during voluntary movement within well-defined spatial (angular) zones. The investigators hypothesize that recovery of voluntary motor control is tightly linked to the recovery of threshold control. The investigators propose a training program that incorporates personalized tDCS to balance cortical hypo/hyperexcitability as well as personalized movement arm reaching training based on the identification of disorders in ST.

Overall objectives of the proposal are:

  1. To test the effectiveness of personalized training programs to increase the range of regulation of STs in the elbow during reaching.
  2. To determine the effects of repetitive tDCS aimed at inhibiting excessive/exciting diminished cortical activity.
  3. To determine the feasibility of implementing personalized training programs in high and low-to-middle income countries.

Sixty patients with sub-acute (3 wks-6 mos) stroke will be recruited in this multi-site international trial taking place in Canada, Israel and India. Participants will have spasticity in the elbow flexors and/or extensors, with some active elbow control. Each site will recruit and randomize patients into one of 3 treatment groups. Group 1 will receive tDCS and practice personalized arm motor training. Group 2 will also receive tDCS with non-specific practice. Group 3 will receive Sham-tDCS and personalized practice. Training will consist of the application of tDCS in the first 30 minutes of a 50-minute arm reaching practice session,, 5 days per week for 2 weeks. Primary outcome measures (Pre, Post, Follow-up) are elbow flexor and extensor STs and related spasticity/active control zones. Secondary measures are clinical measures of UL motor activity. By accounting for the spatial structure of motor deficits, our research will benefit both researchers and clinicians by advancing our understanding of the mechanisms underlying unimpaired/impaired motor control and recovery.

02

Conditions studied

  • Stroke
  • Arm
  • Paresis

Browse trials for

Keywords

  • Transcranial Direct Current Stimulation
  • Arm Training
  • Virtual Reality Exposure Therapy
03

In context

Paresis

519 studies on the registry are indexed under Paresis; 111 are open to participants now.

This study's enrollment of 50 is above the median of 36 across 448 interventional studies indexed under Paresis.

Browse Paresis studies →

Lead sponsor

McGill University is the lead sponsor of 244 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. first ever cortical or cortical/subcortical stroke confirmed by MRI/CT and medically stable;
  2. sub-acute stage of stroke (3 wk to 6 mo post-stroke);
  3. arm paresis (Chedoke-McMaster Arm Scale of 2-6 /7; Gowland et al. 1993) but able to perform voluntary elbow flexion/extension of at least 30° per direction;
  4. elbow flexor and/or extensor spasticity (> 1+/4 on Modified Ashworth Scale; Ashworth 1964; Bohannon and Smith 1987);
  5. able to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  1. major neurological (other than stroke) / neuromuscular / orthopaedic problems or pain that may interfere with interpretation of results;
  2. major cognitive deficits (a score \<20 on the Montreal Cognitive Assessment, Nasreddine et al. 2005);
  3. history of psychiatric disorders, alcohol or drug abuse, skin sensitivity, seizures, migraines, metal in cranium and other implants (cochlear, cardiac);
  4. taking medications (e.g. epileptic and psychoactive drugs) that could affect brain activity (Poreisz 2007).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    tDCS + personalized practice

    Transcranial direct current stimulation and personalized arm motor training limited to active control zones, 1 hour per day, 5 days per week for 2 weeks

    Device: tDCS · Behavioral: personalized practice

  • Active comparator
    tDCS + non-personalized practice

    Transcranial direct current stimulation and non-personalized arm motor training spanning both active control and spasticity zones, 1 hour per day, 5 days per week for 2 weeks

    Device: tDCS · Behavioral: non-personalized practice

  • Sham comparator
    sham tDCS + personalized practice

    Sham transcranial direct current stimulation and personalized arm motor training limited to active control zones, 1 hour per day, 5 days per week for 2 weeks

    Device: sham tDCS · Behavioral: personalized practice

Interventions

  • DevicetDCS

    Application of 1.5 mA tDCS for 30 minutes

  • Devicesham tDCS

    Application of sham tDCS for 30 minutes

  • Behavioralpersonalized practice

    arm exercise consisting of whole arm movement within a restricted elbow range of motion

  • Behavioralnon-personalized practice

    arm exercise consisting of unrestricted whole arm movement

06

What researchers measure

Primary outcomes

  1. Change in active control zone of the elbow

    Post-test and Follow-up test; measured using motion analysis system.

    Time frame: 2 weeks and 1 month

Secondary outcomes

  1. Change in Fugl-Meyer Assessment of arm impairment score

    Post-test and Follow-up test; Score of 66 points indicates normal functioning.

    Time frame: 2 weeks and 1 month

  2. Change in spasticity score

    Post-test and Follow-up test; 6 point ordinal scale

    Time frame: 2 weeks and 1 month

  3. Change in streamlined Wolf Motor Function Test score

    Post-test and Follow-up test;30 point ordinal scale

    Time frame: 2 weeks and 1 month

  4. Change in active range of elbow extension

    Post-test and Follow-up test; measured with a hand-held goniometer

    Time frame: 2 weeks and 1 month

  5. Change in straightness of elbow trajectory during a reach to grasp task

    Post-test and Follow-up test; measured using a motion analysis system

    Time frame: 2 weeks and 1 month

  6. Change in speed of endpoint movement during a reach to grasp task

    Post-test and Follow-up test; measured using a motion analysis system

    Time frame: 2 weeks and 1 month

  7. Change in smoothness of endpoint trajectory during a reach to grasp task

    Post-test and Follow-up test; measured using a motion analysis system

    Time frame: 2 weeks and 1 month

07

Study locations

1 site
  • CRIR
    Montreal, Quebec H2H2N8, Canada
08

References and documents

Publications

  • ASHWORTH B. PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. Practitioner. 1964 Apr;192:540-2. No abstract available. PubMed 14143329 ↗
  • Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. doi: 10.1093/ptj/67.2.206. PubMed 3809245 ↗
  • Gowland C, Stratford P, Ward M, Moreland J, Torresin W, Van Hullenaar S, Sanford J, Barreca S, Vanspall B, Plews N. Measuring physical impairment and disability with the Chedoke-McMaster Stroke Assessment. Stroke. 1993 Jan;24(1):58-63. doi: 10.1161/01.str.24.1.58. PubMed 8418551 ↗
  • Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x. Erratum In: J Am Geriatr Soc. 2019 Sep;67(9):1991. doi: 10.1111/jgs.15925. PubMed 15817019 ↗
  • Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007 May 30;72(4-6):208-14. doi: 10.1016/j.brainresbull.2007.01.004. Epub 2007 Jan 24. PubMed 17452283 ↗
  • Levin MF, Banina MC, Frenkel-Toledo S, Berman S, Soroker N, Solomon JM, Liebermann DG. Personalized upper limb training combined with anodal-tDCS for sensorimotor recovery in spastic hemiparesis: study protocol for a randomized controlled trial. Trials. 2018 Jan 4;19(1):7. doi: 10.1186/s13063-017-2377-6. PubMed 29301545 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02725853
Lead sponsor
McGill University
Collaborators
Tel Aviv University, Manipal University
Responsible party
Mindy F. Levin (Professor, McGill University) — Principal investigator
First posted
Apr 1, 2016
Start date
Jun 2016
Primary completion
Sep 2020
Completion
Dec 1, 2021
Last update
Jan 3, 2022

Study contacts

Mindy F Levin, PhD
principal investigator · McGill University
Dario G Liebermann, PhD
principal investigator · Tel Aviv University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion